Progenity to Become Biora Therapeutics as it Completes Transformation
12 Abril 2022 - 10:00AM
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating
in the field of oral biotherapeutics for gastrointestinal health
and beyond, today announced that it will change its name to Biora
Therapeutics, Inc. during the second quarter of 2022, to better
reflect the company’s focus on developing its pipeline for targeted
and systemic oral delivery of biotherapeutics.
“As we complete our strategic transformation, we are launching
Biora Therapeutics to reflect our mission going forward, which is
to reimagine therapeutics and their delivery,” said Adi Mohanty,
Chief Executive Officer. “By creating innovative smart pills
designed for targeted drug delivery to the GI tract and for
systemic, needle-free delivery of biotherapeutics, we are
developing therapies to improve patients’ lives.”
Progenity expects the brand launch for Biora Therapeutics™ to
coincide with the company’s Q1 2022 earnings call in May, and the
company’s NASDAQ ticker symbol will also change from “PROG” to
“BIOR” at that time. No action is needed from current stockholders.
The company’s Class A common stock will continue to be listed on
NASDAQ and the CUSIP will not change. The legal name change is
expected to be completed on or about April 26, 2022, upon
satisfying all applicable requirements.
For updates about Biora Therapeutics, please follow @BioraThera
on Twitter.
About ProgenityProgenity, Inc. is a
biotechnology company innovating in the fields of gastrointestinal
health and oral biotherapeutics and is developing a suite of
investigational ingestible devices designed to provide precise drug
delivery solutions and diagnostic sampling. Progenity will become
Biora Therapeutics, Inc. during the second quarter of 2022.
For more information visit www.progenity.com, or follow the
company on LinkedIn or Twitter.
Investor ContactChuck PadalaManaging Director,
LifeSci Advisorsir@progenity.com (917) 741-7792
Media ContactKristin SchaefferCG
Lifemedia@progenity.com (858) 457-2436
Biora Therapeutics (NASDAQ:PROG)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Biora Therapeutics (NASDAQ:PROG)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Biora Therapeutics Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de